These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 14306952)
21. SERUM SICKNESS AND PLASMACYTOSIS. A CLINICAL, IMMUNOLOGIC AND HEMATOLOGIC ANALYSIS. BARNETT EV; STONE G; SWISHER SN; VAUGHAN JH Am J Med; 1963 Jul; 35():113-22. PubMed ID: 14045997 [No Abstract] [Full Text] [Related]
22. Active-passive immunization of human subjects against tetanus using homologous gamma globulin. Matveev KI; Skurkovich SV; Bychenko BD; Kasparova EM; Konstantinova ND; Minaeva HL J Hyg Epidemiol Microbiol Immunol; 1974; 18(2):246-51. PubMed ID: 4137523 [No Abstract] [Full Text] [Related]
23. Early and enhanced antioxin responses elicited with complexes of tetanus toxoid and specific mouse and human antibodies. Stoner RD; Terres G; Hess MW J Infect Dis; 1975 Mar; 131(3):230-8. PubMed ID: 47882 [TBL] [Abstract][Full Text] [Related]
25. [The treatment of tetanus with massive doses of refined tetanus antitoxin globulins]. VERHAGEN H Ned Tijdschr Geneeskd; 1951 Apr; 95(16):1347-9. PubMed ID: 14843254 [No Abstract] [Full Text] [Related]
26. TETANUS PREVENTION. HARA B J Am Podiatry Assoc; 1965 Aug; 55():599-601. PubMed ID: 14342814 [No Abstract] [Full Text] [Related]
27. [Anaphylactic shock following administration of Fermo-tetanus antitoxin as a tolerance test]. KRAUSE E Monatsschr Unfallheilkd Versicherungsmed; 1960 Sep; 63():352-4. PubMed ID: 13754080 [No Abstract] [Full Text] [Related]
28. [Current problems related to the further reduction and elimination of tetanus (literature review)]. Matveev KI; Sergeeva TI Zh Mikrobiol Epidemiol Immunobiol; 1972 Dec; 49(12):36-43. PubMed ID: 4118731 [No Abstract] [Full Text] [Related]
29. THE PROPHYLAXIS OF TETANUS. BETTMAN JW Am J Ophthalmol; 1963 Nov; 56():806-10. PubMed ID: 14077186 [No Abstract] [Full Text] [Related]
30. [Adequate dosage of tetanus antitoxin and tetanus-immune human gamma globulin TIG in the treatment of tetanus]. Ebisawa I Masui; 1974 May; 23(5):381-7. PubMed ID: 4137369 [No Abstract] [Full Text] [Related]
37. [Evaluation of antitoxin and antibacterial activity of human preparations of normal immunoglobulin. I. Level of tetanus antitoxin in preparations of IMIG and IVIG]. Zakrzewska A; Rymkiewicz D Przegl Epidemiol; 1995; 49(4):381-4. PubMed ID: 8868196 [TBL] [Abstract][Full Text] [Related]
38. [Immunological prevention of tetanus in hospitals: practical notes]. Di Rocco P Ig Mod; 1970; 63(1):38-46. PubMed ID: 4098587 [No Abstract] [Full Text] [Related]
39. [Prevention of tetanus]. Arsić B Vojnosanit Pregl; 1969 Sep; 26(9):452-60. PubMed ID: 4188956 [No Abstract] [Full Text] [Related]
40. [Iatrogenic disease in the prevention of tetanus]. Ott K Rozhl Chir; 1967 Jul; 46(7):493-5. PubMed ID: 4168782 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]